2011 South African Data Centre Green Excellence Award in Technology Innovation                                            ...
BEST PRACTICES RESEARCHCompany of the Year AwardIntegrated Biobanking SolutionsGlobal, 2011Frost & Sullivan’s Global Resea...
BEST PRACTICES RESEARCHimportant to preserve samples from different timelines, as the demands and therequirements of the r...
BEST PRACTICES RESEARCH                C ha r t 1 : B es t P ra c t i c es L ev e ra g e f o r Gr ow t h Ac c e l era t i ...
BEST PRACTICES RESEARCHDecision Support Matrix and Measurement CriteriaTo support its evaluation of best practices across ...
BEST PRACTICES RESEARCHBest Practice Award Analysis for Thermo Fisher ScientificThe Decision Support Matrix, shown in Char...
BEST PRACTICES RESEARCHcollaborate and share with other research organizations participating in the program. TheCentralize...
BEST PRACTICES RESEARCHCriterion 3: Degree of Innovation with Products and TechnologiesThermo      Fisher        Scientifi...
BEST PRACTICES RESEARCHThe Microsoft-based LIMS solutions offered by Thermo Fisher Scientific have set recordsfor breakthr...
BEST PRACTICES RESEARCHThermo      Fisher        Scientific   is   working   closely   with   a   number    of   long-term...
BEST PRACTICES RESEARCHThe CEO 360-Degree Perspective T M - Visionary Platform for GrowthStrategiesThe CEO 360-Degree Pers...
BEST PRACTICES RESEARCHCritical Importance of TEAM ResearchFrost & Sullivan’s TEAM Research methodology represents the ana...
Upcoming SlideShare
Loading in …5
×

2011 global integrated biobanking solutions company of the year award

1,216 views

Published on

www.thermoscientific.com/biobankingresources

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,216
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

2011 global integrated biobanking solutions company of the year award

  1. 1. 2011 South African Data Centre Green Excellence Award in Technology Innovation Cybernest 2011 2011 Global Integrated Biobanking Solutions Company of the Year Award© 2011 Frost & Sullivan 1 “We Accelerate Growth”
  2. 2. BEST PRACTICES RESEARCHCompany of the Year AwardIntegrated Biobanking SolutionsGlobal, 2011Frost & Sullivan’s Global Research PlatformFrost & Sullivan is in its 50th year in business with a global research organization of 1,800analysts and consultants who monitor more than 300 industries and 250,000 companies.The company’s research philosophy originates with the CEO’s 360-Degree Perspective™,which serves as the foundation of its TEAM Research™ methodology. This unique approachenables us to determine how best-in-class companies worldwide manage growth,innovation and leadership. Based on the findings of this Best Practices research, Frost &Sullivan is proud to present the 2011 Global Company of the Year Award in IntegratedBiobanking Solutions to Thermo Fisher Scientific(www.thermoscientific.com/biobankingresources).Significance of the Company of the Year AwardKey Industry Challenges Addressed by Int egrated Biobanki ng SolutionsThe global biobanking industry is characterized by many newly established national andregional disease-specific biobanks. Common challenges faced by every biobank are sampleidentification, sample tracking, maintaining sample integrity, and lack of accurate andaccessible inventory. Biosample resources come together through a complex chain ofcooperation across collection, preservation, storage, retrieval, and research. The value ofthese biosamples lies not only in the samples themselves but with the metadataassociated with each specimen. Information Management (IM) helps simplify data frominventory management through management of samples, and data analysis, and results.The research and development space has compelled the biorepositories to seek newproducts and services that could support efficient and effective sample utilization. Serviceproviders and vendors face a tough challenge associated with clients’ varyingspecifications, as no two biobanks operate with the same standards and specifications.In such a scenario, implementing a significant degree of leadership and innovation in itsbusiness processes and growth strategy can allow a vendor to strengthen its ability tosupport clients. Besides, by providing an end-to-end portfolio of products and services forbiobanking, vendors can target a wider client base and solve many of their most pressingneeds. Furthermore, a competitive pricing strategy for its products and services willbenefit both the vendor and the customer in the long run.Many biobanks are publicly funded and hence struggle to cut costs. Cost cutting isachieved by discarding superfluous samples, in order to create space for the growingnumber of new samples. Having a broad portfolio of solutions for biobanking can,therefore, help tackle storage, sample handling and data management issues. It is© 2012 Frost & Sullivan 1 “We Accelerate Growth”
  3. 3. BEST PRACTICES RESEARCHimportant to preserve samples from different timelines, as the demands and therequirements of the research and development (R&D) drug discovery community arediverse and continuous. Advanced medicine requires next generation informaticssolutions.Impact of Company of the Year Aw ard on Key StakeholdersThe Company of the Year Award is a prestigious recognition of Thermo Fisher Scientific’saccomplishments in Integrated Biobanking Solutions. An unbiased, third-party recognitioncan provide a profound impact in enhancing the brand value and accelerating ThermoFisher Scientific’s growth. As captured in Chart 1 below, by researching, ranking, andrecognizing those who deliver excellence and best practices in their respective endeavors,Frost & Sullivan hopes to inspire, influence, and impact three specific constituencies: • Investors Investors and shareholders always welcome unbiased and impartial third-party recognition. Similarly, prospective investors and shareholders are drawn to companies with a well-established reputation for excellence. Unbiased validation is the best and most credible way to showcase an organization worthy of investment. • Customers Third-party industry recognition has been proven to be the most effective way to assure customers that they are partnering with an organization that is leading in its field. • Employees This Award represents the creativity and dedication of Thermo Fisher Scientific’s executive team and employees. Such public recognition can boost morale and inspire your team to continue its best-in-class pursuit of a strong competitive position for Thermo Fisher Scientific.© 2012 Frost & Sullivan 2 “We Accelerate Growth”
  4. 4. BEST PRACTICES RESEARCH C ha r t 1 : B es t P ra c t i c es L ev e ra g e f o r Gr ow t h Ac c e l era t i onKey Benchmarking Criteria f or Company of the Year Aw ardFor the Company of the Year Award, the following criteria were used to benchmarkThermo Fisher Scientific’s performance against key competitors: • Growth Strategy Excellence • Growth Implementation Excellence • Degree of Innovation with Products and Technologies • Leadership in Customer Value • Leadership in Market Penetration© 2012 Frost & Sullivan 3 “We Accelerate Growth”
  5. 5. BEST PRACTICES RESEARCHDecision Support Matrix and Measurement CriteriaTo support its evaluation of best practices across multiple business performancecategories, Frost & Sullivan employs a customized Decision Support Matrix (DSM). TheDSM is an analytical tool that compares companies’ performance relative to each otherwith an integration of quantitative and qualitative metrics. The DSM features criteriaunique to each Award category and ranks importance by assigning weights to eachcriterion. The relative weighting reflects current market conditions and illustrates theassociated importance of each criterion according to Frost & Sullivan. Fundamentally, eachDSM is distinct for each market and Award category. The DSM allows our research andconsulting teams to objectively analyze each companys performance on each criterionrelative to its top competitors and assign performance ratings on that basis. The DSMfollows a 10-point scale that allows for nuances in performance evaluation; ratingsguidelines are shown in Chart 2. C ha r t 2 : P erf o rm a n c e- Ba s e d Ra t i ng s f o r De c is i on S u pp o r t Ma tr i xThis exercise encompasses all criteria, leading to a weighted average ranking of eachcompany. Researchers can then easily identify the company with the highest ranking. As afinal step, the research team confirms the veracity of the model by ensuring that smallchanges to the ratings for a specific criterion do not lead to a significant change in theoverall relative rankings of the companies. C ha r t 3 : Fr os t & S ul l iva n’s 10-S t e p P r oc es s f or I de n t if y in g Aw a rd R ec ip i en ts© 2012 Frost & Sullivan 4 “We Accelerate Growth”
  6. 6. BEST PRACTICES RESEARCHBest Practice Award Analysis for Thermo Fisher ScientificThe Decision Support Matrix, shown in Chart 4, illustrates the relative importance of eachcriterion for the Company of the Year Award and the ratings for each company underevaluation. To remain unbiased while also protecting the interests of the otherorganizations reviewed, we have chosen to refer to the other key players as Competitor 1and Competitor 2. C ha r t 4 : D ec is io n S u p po r t M a t ri x f or C o mp a n y of t he Y ea r Aw a r d Measurement of 1–10 (1 = lowest; 10 = highest) Award Criteria Growth Strategy Excellence Products and Technologies Degree of Innovation with Growth Implementation Leadership in Customer Leadership in Market Weighted Rating Penetration Excellence Value Relative Weight (%) 20% 20% 20% 20% 20% 100% Thermo Fisher Scientific 8 9 7 8 8 8.00 Competitor 1 7 7 6 7 7 6.80 Competitor 2 6 7 5 6 6 6.00Criterion 1: Growth Strategy ExcellenceThermo Fisher Scientific is the world’s largest provider of biobanking products, servicesand solutions, enabling its customer to make the world healthier, cleaner and safer. Thecompany continues to build on its global brand image by executing an aggressive growthstrategy. During the analysis of this award, it was clear that Thermo Fisher Scientific’saward winning biobanking products aimed to improve quality and simplify themanagement of biobanks. The company has delivered complete biobanking solutions tocustomers unlike its competitors in the market. Thermo Fisher Scientific has alwaysstayed ahead of the competition by continually delivering innovative biobanking productsand venturing into the latest creative collaborative projects, such as virtual biobanks,where the samples reside in multiple biobanks. Researchers need to locate samples for aparticular disease and/or patient population. The National Cancer Institute’s (NCI)Common Biorepository Model (CBM) is one such model introduced in 2011. Thermo FisherScientific is working with the NCI to search for biospecimens across the networkcomprising CRO’s, dedicated biobanks, pharmaceutical companies, biotech companies anduniversities. This will enable the researchers to locate the samples they need and© 2012 Frost & Sullivan 5 “We Accelerate Growth”
  7. 7. BEST PRACTICES RESEARCHcollaborate and share with other research organizations participating in the program. TheCentralized Research Biorepository model aims to capture the total collection, processingand storage workflow and makes the data available to multiple global users. With thestate-of-the-art scheduling software and unequalled choice of robot movers, ThermoFisher Scientific provides a comprehensive automated workflow for sample preparation,storage and analysis.Criterion 2: Growth Implementation ExcellenceThermo Fisher Scientific’s growth plan focuses on several key areas, such as addingfunctionality to deliver innovative biobanking products to the market, providingcompetitive products, administering complete end-to-end solutions to customers, andkeeping ahead of new trends in the market. This has given Thermo Fisher a reputation inthe industry as a solid provider with strong customer references.Automation is a critical component of any biobank. With over 20 years of experience inlaboratory automation, Thermo Fisher Scientific provides automated solutions for samplearraying / re-formatting, DNA, RNA & Protein extraction, ELISA / Immunoassays, andbiochemical assays. Some biobanks, such as the UK Biobank, have been extensivelyplanned with automation to facilitate intended large storage capacity (15 million aliquots)and desired retrieval rates. Being the market leader in the Laboratory InformationManagement Systems (LIMS) sector and the consumables sector, Thermo Fisher Scientificproducts enable biobanks to ensure sample consistency and control their processes.Fisher BioServices is the cornerstone of Thermo Fisher Scientific’s unparalleled support toall segments of the biobanking industry. Fisher BioServices provides its customers withnumerous biobanking services, including cold chain transportation, specimen inventorymanagement, molecular lab and specimen processing services, sample collection kitassembly within a documented quality system. With a significant double digit growth ratein revenues since 2009, Fisher BioServices has set out to evaluate initiatives to cut downon power usage and other cost saving measures. Over the past couple of years, FisherBioServices has installed new lighting in some of its repositories that utilize less power,coupled with motion sensors, to activate the lights only when someone is moving in thatpart of the repository. These lights automatically turn-off after a certain time when no oneis in that area. Yet another remarkable observation from Fisher BioServices is itsoutstanding achievement in recycling solid waste. Fisher BioServices achieved a recyclingrate of 63 per cent for both required and voluntary materials in 2011.In addition, having a global presence and strong brand image has only strengthenedThermo Fisher Scientific’s position in the global biobanking market.© 2012 Frost & Sullivan 6 “We Accelerate Growth”
  8. 8. BEST PRACTICES RESEARCHCriterion 3: Degree of Innovation with Products and TechnologiesThermo Fisher Scientific has showcased end-to-end solutions for biobanks andbiorepositories. With an increasing trend towards automation and more effective solutionsfor storage and sample handling, Thermo Fisher Scientific has bestowed the biobankingsector with comprehensive solutions that address the key challenges within the biobankingworkflow. The solutions from Thermo Fisher Scientific have set out to meet the needs ofboth large and small scale organizations, starting from CRO’s to large biotech facilities,worldwide. Thermo Fisher Scientific is a one-stop shop, as it delivers software, samplehandling and automation equipment, consumables, reagents and biobanking services, toits customers. Due to their exceptional expertise in the area of informatics, the processes,including sample collection, processing, testing, storage and data management, can bemanaged seamlessly. The portfolio of biobanking products from Thermo Fisher Scientifichave effectively addressed issues pertaining to sample location management, sampleretrieval, preservation of sample integrity and accuracy with regard to accessing samples.These solutions have been developed after an extensive understanding of the customerbusinesses and then configured to reflect their business processes. The provision of theright technology and the right solution has facilitated collaboration on a global scale,which will accelerate research and near- term growth in the field of personalized medicine.Thermo Fisher Scientific’s storage and tracking portfolio comprises Thermo ScientificNunc and Matrix 2D integral barcoded tubes of varying volumes, Thermo Scientific Capit-All and Handheld decappers and VisionMate 2D readers. These products work together topreserve samples and assist with their handling and tracking. The cold storage offeringsinclude solutions from +4 °C refrigerators to -196 °C cryogenic freezers. . In 2011,Thermo Scientific Clinical LIMS was an important addition to the Thermo Fisher Scientificportfolio of products that addresses a critical need in the field of personalized medicine,which supports the rapid delivery of results directly from the lab to the patients bedside.The Clinical LIMS offers a lab-centric solution for patient-centric results. To complete theportfolio, Fisher BioServices provides biorepository services, sample collection kitsand sample processing services including aliquoting, DNA/RNA extraction andamplification, and other processing for genomic studies. All services are supported byglobal cold chain logistics expertise. Fisher BioServices houses over 170,000,000 samplesin its facilities across the globe.Criterion 4: Leadership in Customer ValueThermo Scientific LIMS customers have pointed out that the solution sets new standardsin functionality and enables the efficient use of biobanking resources. Built on theMicrosoft .NET platform, the LIMS is easy to implement and has eliminates the need forrigorous training and dedicated IT staff. The flexibility, adaptability and stability of ThermoScientific LIMS combined with Thermo Fisher Scientific’s long established experienceserving the health sciences and pharmaceutical industries has made Thermo ScientificLIMS the obvious choice for the data management of many massive biobanking projects.© 2012 Frost & Sullivan 7 “We Accelerate Growth”
  9. 9. BEST PRACTICES RESEARCHThe Microsoft-based LIMS solutions offered by Thermo Fisher Scientific have set recordsfor breakthroughs in business processes and practices throughout the pharmaceutical andlife sciences industry. Some notable customer laboratories are UK Biobank, HUNTResearch Center and Biobank, AstraZeneca R&D center and Nova Biologicals Ltd that havereaped enormous efficiency gains due to global coordination of requests and automatingworkflow. Customers have pointed out that Thermo Scientific LIMS has delivered superiordata capture, integration and automation capabilities, eliminating transcription errors,providing biobanks with access to both raw and derived data and lowering the Total Costof Ownership (TCO) for its LIMS investment. By improving efficiency and data reliability,the system has enabled more informed decisions faster than ever. Customers of ThermoScientific LIMS opine that the quantitative benefits of the LIMS implementation aredetailed in improved cost savings that include maintenance and integration, efficiency,data quality and traceability. They are far outweighed by the qualitative impact thissolution has on the life science research community. This is primarily because seamlesscommunication, sharing and collaboration across the biobank and external consortium arethe collective goals to advance discoveries amongst a community of institutions.Criterion 5: Leadership in Market PenetrationUnlike its other competitors, Thermo Fisher Scientific is uniquely positioned in this marketbecause of the rich portfolio and the depth of expertise it possesses in each of the servicesrequired for an end-to-end biobanking solution. Globally, Frost & Sullivan forecasts thatthe LIMS (laboratory information management system) market segment for biobanking isgrowing at CAGR of 9 percent from 2012 to 2018, with most of the growth beinggenerated from the revenue contribution by Thermo Fisher Scientific. This has been drivenby a strong focus by governments and organizations on epidemiology and the need forprimary samples for in vitro research. Frost & Sullivan forecasts that the consumablessector of the biobanks will experience the fastest growth rate amidst all the othersegments of biobanking. The growth of biobanking consumables is forecasted to grow at acompound annual growth rate (CAGR) of 12 percent from 2012 to 2018. Thermo FisherScientific strongly believes that the addition of tubes to the 2D product line and otherproducts that universalize its racks, tube capping interfaces and cost-effective cappingsystems, will positively influence its market share. The LIMS sector of Thermo FisherScientific has a strong presence in Europe, especially after acquiring strong customerprojects, from UK Biobank, Hunt Biobank and University of Lund in 2010-2011. Acontinued growth has been perceived in Europe ever since the completion of theseprojects. In North America, there are a lot of upcoming academic and biotech biobankprojects who seek a standardized solution across their consortium, such as the EmoryUniversity. Thermo Fisher Scientific is also supporting business models that involve virtualbiobanks, who want to centralize the information about the status of a particular disease.An attempt to create a centralized inventory has generated the benefits, such as globalview of inventory, centralized web access data, chain of custody, online sampleregistration and tracking, and so on for its customers.© 2012 Frost & Sullivan 8 “We Accelerate Growth”
  10. 10. BEST PRACTICES RESEARCHThermo Fisher Scientific is working closely with a number of long-term largepharmaceutical customers to revolutionize biobanking.ConclusionThermo Fisher Scientific offers end-to-end support for biorepositories and its FisherBioServices business is the only player in the market to provide a spectrum of services,starting from collection, transportation, and inventory to repository. In addition, ThermoFisher Scientific provides best of breed cold storage equipment, consumables forbiobanking, liquid handling tools such as automated pipettes and market-leadinginformatics software for the biobanking industry. Currently, there are no other marketparticipants with such a diverse and cutting edge portfolio for the biobanking industry.Whether clients are building, expanding, or sustaining their own in-house biorepositoriesor needing to store their samples, Thermo Fisher Scientific’s extensive product offeringexhibited excellence in all areas of the market penetration process by efficientlyidentifying challenges in the market and developing strategies, products and services toeffectively address them (www.thermoscientific.com/biobankingresources).© 2012 Frost & Sullivan 9 “We Accelerate Growth”
  11. 11. BEST PRACTICES RESEARCHThe CEO 360-Degree Perspective T M - Visionary Platform for GrowthStrategiesThe CEO 360-Degree Perspective™ model provides a clear illustration of the complexbusiness universe in which CEOs and their management teams live today. It representsthe foundation of Frost & Sullivans global research organization and provides the basis onwhich companies can gain a visionary and strategic understanding of the market. The CEO360-Degree Perspective™ is also a “must-have” requirement for the identification andanalysis of best-practice performance by industry leaders.The CEO 360-Degree Perspective™ model enables our clients to gain a comprehensive,action-oriented understanding of market evolution and its implications for their companies’growth strategies. As illustrated in Chart 5 below, the following six-step process outlineshow our researchers and consultants embed the CEO 360-Degree Perspective™ into theiranalyses and recommendations.C ha r t 5 : H ow th e C E Os 3 60- De g r ee P e rs p ec ti v e™ M od e l Di r e c ts Ou r R e s e a rc h© 2012 Frost & Sullivan 10 “We Accelerate Growth”
  12. 12. BEST PRACTICES RESEARCHCritical Importance of TEAM ResearchFrost & Sullivan’s TEAM Research methodology represents the analytical rigor of ourresearch process. It offers a 360-degree view of industry challenges, trends, and issues byintegrating all seven of Frost & Sullivans research methodologies. Our experience hasshown over the years that companies too often make important growth decisions based ona narrow understanding of their environment, leading to errors of both omission andcommission. Frost & Sullivan contends that successful growth strategies are founded on athorough understanding of market, technical, economic, financial, customer, bestpractices, and demographic analyses. In that vein, the letters T, E, A and M reflect ourcore technical, economic, applied (financial and best practices) and market analyses. Theintegration of these research disciplines into the TEAM Research methodology provides anevaluation platform for benchmarking industry players and for creating high-potentialgrowth strategies for our clients. C ha r t 6 : B e nc h ma r ki ng P e rf or ma nc e w i t h TE A M R es ea rc hAbout Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growthand achieve best-in-class positions in growth, innovation and leadership. The companysGrowth Partnership Service provides the CEO and the CEOs Growth Team with disciplinedresearch and best-practice models to drive the generation, evaluation and implementationof powerful growth strategies. Frost & Sullivan leverages 50 years of experience inpartnering with Global 1000 companies, emerging businesses and the investmentcommunity from more than 40 offices on six continents. To join our Growth Partnership,please visit http://www.frost.com.© 2012 Frost & Sullivan 11 “We Accelerate Growth”

×